Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Conformationally restricted analogues of the antibacterial agent trimethoprim (TMP) were designed to mimic the conformation of drug observed in its complex with bacterial dihydrofolate reductase (DHFR). This conformation of TMP was achieved by linking the 4-amino function to the methylene group by one- and two-carbon bridges. A pyrrolo[2,3-d]pyrimidine, a dihydro analogue, and a tetrahydropyrido[2,3-d]pyrimidine were synthesized and tested as inhibitors of DHFR. One analogue showed activity equivalent to that of TMP against DHFR from three species of bacteria. An X-ray crystal structure of this inhibitor bound to Escherichia coli DHFR was determined to evaluate the structural consequences of the conformational restriction.

Type

Journal article

Journal

Bioorg Med Chem

Publication Date

04/1996

Volume

4

Pages

593 - 602

Keywords

Animals, Anti-Infective Agents, Urinary, Binding Sites, Crystallography, X-Ray, Escherichia coli, Folic Acid Antagonists, Humans, Hydrogen Bonding, Liver, Molecular Conformation, Neisseria gonorrhoeae, Plasmodium berghei, Rats, Staphylococcus aureus, Structure-Activity Relationship, Trimethoprim